- Home
- AIRT vs CVM Comparison
AIRT vs CVM Comparison
Compare AIRT & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRT | CVM |
|---|---|---|
| Founded | 1980 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.2M | 53.1M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | AIRT | CVM |
|---|---|---|
| Price | $20.01 | $6.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.6K | ★ 58.9K |
| Earning Date | 11-12-2025 | 01-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $279,216,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.56 | $1.98 |
| 52 Week High | $26.70 | $32.70 |
Technical Indicators
Market Signals| Indicator | AIRT | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 45.03 | 42.89 |
| Support Level | $18.42 | $6.20 |
| Resistance Level | $19.65 | $6.69 |
| Average True Range (ATR) | 0.41 | 0.54 |
| MACD | -0.02 | 0.05 |
| Stochastic Oscillator | 48.12 | 35.71 |
Price Performance
Historical ComparisonAbout AIRT Air T Inc.
Air T Inc together with its subsidiaries provides air freight service to the express delivery industry. The company's operating segments include Overnight air cargo, Ground equipment sales, Commercial jet engines, and parts, Corporate, and Others. The company generates maximum revenue from the Commercial Jet Engines and Parts segment.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.